MedPath

Survival Among Patients With Pancreatic Cancer Depending on Surgical Resection Rate

Completed
Conditions
Pancreatic Ductal Adenocarcinoma
Interventions
Other: Resection rates
Registration Number
NCT04802993
Lead Sponsor
Linkoeping University
Brief Summary

The primary aim of this population-based study is to investigate how a high resection rate of pancreaticoduodenectomy affects overall survival among patients aged ≥70 years with pancreatic ductal adenocarcinoma. The secondary aim is to determine if a high resection rate of pancreaticoduodenectomy increases perioperative morbidity.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
5123
Inclusion Criteria
  • Diagnosed between 1 January 2010 and 31 December 2018
  • Registered in the Swedish National Registry for tumours in the pancreatic and periampullary region
  • Either a diagnosis of pancreatic ductal adenocarcinoma of the pancreatic head or having been resected with pancreaticoduodenectomy
Exclusion Criteria
  • None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
All patients with pancreatic ductal adenocarcinoma aged 70-79 yearsResection ratesAll patients in the registry aged 70-79 years with right-sided pancreatic ductal adenocarcinoma
All patients resected with pancreaticoduodenectomy, aged 80 years and olderResection ratesAll patients in the registry resected with pancreaticoduodenectomy during the study period, aged 80 years and older
All patients with pancreatic ductal adenocarcinoma aged 80 years and olderResection ratesAll patients in the registry aged 80 years and older with right-sided pancreatic ductal adenocarcinoma
All patients resected with pancreaticoduodenectomy, all agesResection ratesAll patients in the registry resected with pancreaticoduodenectomy during the study period
All patients with pancreatic ductal adenocarcinoma aged 70 years and olderResection ratesAll patients in the registry aged 70 years and older with right-sided pancreatic ductal adenocarcinoma
All patients resected with pancreaticoduodenectomy, aged 70-79 yearsResection ratesAll patients in the registry resected with pancreaticoduodenectomy during the study period, aged 70-79 years
Primary Outcome Measures
NameTimeMethod
Overall survivalA little more than 10 years (from first patient to vital status)

Overall survival among patients aged 70 years and over with pancreatic ductal adenocarcinoma in the pancreatic head

Secondary Outcome Measures
NameTimeMethod
Severe complications after pancreaticoduodenectomyAround 10 years (patients diagnosed between 1 January 2010 and 31 December 2018, latest dismissal from hospital january 2020)

The rate of severe complications among patients aged 70 years and over who had undergone pancreaticoduodenectomy for any reason

© Copyright 2025. All Rights Reserved by MedPath